Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Motor Activity × Oxaliplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 74 Stomach Neoplasms 49 Rectal Neoplasms 41 Colonic Neoplasms 38 Pancreatic Neoplasms 17 Neoplasms 14 Neoplasm Metastasis 11 Carcinoma, Hepatocellular 10 Lymphoma, Large B-Cell, Diffuse 9 Cholangiocarcinoma 8 Adenocarcinoma Of Esophagus 8 Adenocarcinoma 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Esophageal Neoplasms 5 Esophageal Squamous Cell Carcinoma 4 Gallbladder Neoplasms 3 Biliary Tract Neoplasms 3 Neurotoxicity Syndromes 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphoma 2 Gastrointestinal Neoplasms 2 Gastrointestinal Diseases 2 Colorectal Adenocarcinoma 2 Resectable Colon Cancer 1 Rectal Diseases 1 Radiation Injuries 1 Peritoneal Neoplasms 1 Patient Compliance 1 Pathologic Complete Response 1 Paresthesia 1

Interventions

Exercise 8 tislelizumab 1 Vitamin D 1 Tea 1 Resistance Training 1 Probiotics 1 Oxaliplatin 1 Nutrition Assessment 1 Metformin 1 Leucovorin 1 Fluorouracil 1 Fish Oils 1 Diet Therapy 1 Diet 1 Curcumin 1 Counseling 1 Capecitabine 1 Caloric Restriction 1 Andrographis paniculata extract 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04488159 2024-09-20

iMAGINE

Medical University of Vienna

Phase 3 Withdrawn

Gastrointestinal

Colonic Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡